Roche Holding AG has launched a program that guarantees supplies of its influenza drug Tamiflu to U.S. companies in the event of a flu pandemic. The program, which requires a minimum order of 2,500 courses of the drug at $6 each, is part of the Swiss drugmaker's strategy to recover from slumping sales of the treatment.

Related Summaries